Back to News
Market Impact: 0.5

China Vanke Co. (SEHK:2202) Price Target Decreased by 17.11% to 5.14

VGTSXVEIEXIEMGFNDENDAQ
Analyst EstimatesAnalyst InsightsInvestor Sentiment & PositioningMarket Technicals & FlowsCompany FundamentalsEmerging Markets
China Vanke Co. (SEHK:2202) Price Target Decreased by 17.11% to 5.14

The average one-year price target for China Vanke Co. (SEHK:2202) has been lowered by 17.11% to HK$5.14/share, although this still implies a 19.55% upside from its recent closing price of HK$4.30. Institutional ownership data indicates a slight decrease in the number of funds holding positions and total shares owned, yet the average portfolio weight dedicated to Vanke by these funds increased by 9.16%, suggesting a nuanced shift in institutional allocation despite reduced overall exposure.

Analysis

The average one-year price target for China Vanke Co. (SEHK:2202) has been significantly reduced by 17.11% to HK$5.14 per share from a prior HK$6.20 estimate. Despite this new target still implying a 19.55% upside from the current HK$4.30 closing price, the substantial downgrade signals a deteriorating analyst outlook. The wide target range, from HK$3.22 to HK$8.40, underscores considerable uncertainty among experts. Institutional ownership data indicates a slight decrease in the number of funds holding positions (down 1.08%) and total shares owned (down 0.06%) over the last quarter. While the average portfolio weight dedicated to 2202 across all funds increased by 9.16% to 0.04%, this aggregate figure masks more specific trends among major holders. Key institutional investors like VGTSX, VEIEX, IEMG, and FNDE, despite some increasing their absolute share counts, significantly decreased their portfolio allocation in 2202 by 13.14% to 28.43% respectively. This strategic underweighting suggests a rebalancing away from China Vanke within their broader portfolios, reflecting reduced conviction. This collective institutional behavior, combined with the analyst downgrade and a general "moderately negative" sentiment, points to ongoing challenges for China Vanke. Investors should interpret the implied upside from the revised price target with caution, given the evident institutional repositioning.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.